HealthPhoto: Deccan HeraldWHO Sets New Targets for Long-Acting Tuberculosis Injections
The World Health Organization (WHO) has established new targets for long-acting injectables (LAIs) to improve tuberculosis (TB) prevention and treatment. Current TB regimens require daily oral medication over months, which is challenging for many. LAIs could simplify treatment by reducing dosing frequency without compromising efficacy or safety. Several LAI candidates for TB are nearing clinical development, aiming for shorter, simpler regimens.
Deccan Herald·



